Is early diagnosis of pancreatic cancer fiction? surveillance of individuals at high risk for pancreatic cancer

Digestive Diseases

Volumn 28, Issue 4-5, 2010, Pages 670-678

  Harinck, F ^a   Poley, J W ^a   Kluijt, I ^b   Fockens, P ^c   Bruno, M J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Familial pancreatic cancer; Pancreatic cancer susceptibility; Surveillance

Indexed keywords

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CASE FINDING; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; EARLY CANCER; ENDOSCOPIC ECHOGRAPHY; FAMILIAL CANCER; FOLLOW UP; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST;

EARLY DETECTION OF CANCER; HEALTH POLICY; HUMANS; PANCREATIC NEOPLASMS; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 78649354230     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320095     Document Type: Conference Paper

References (44)

1. Starling N, Cunningham D: Survival from cancer of the pancreas in England and Wales up to 2001. British J Cancer 2008; 99(suppl 1):S 24 - S25.
2. Soreide K, Aagnes B, Moller B, Westgaard A, Bray F: Epidem iolog y of pa ncreat ic Cancer i n Norway: trends in incidence, basis of diagnosis and survival 1965-2007. Scand J Gastroenterol 2010;45: 82-92.
3. Gollust SE, Schroeder SA, Warner KE: Helping smokers quit: understanding the barriers to utilization of smoking cessation services. Milbank Q 2008; 86:601-627.
4. Wilson JMG, Jungner G: Principles and Practice of Screening for Disease. Public Health Papers, No. 34. Geneva, WHO, 1968.
5. Intergrale Kankercentra, Nederland. www. ikcnet.nl.
6. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 1 8 : 581-592.
7. Lynch HT, Smyrk T, Kern SE, Hruban RH, Lightdale CJ, Lemon SJ, Lynch JF, Fusaro LR, Fusaro RM, Ghadirian P: Familial pancreatic cancer: a review. Sem Oncol 1996; 23: 251-275.
8. Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI: Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007; 56: 1460-1469.
9. Vasen HF, Gruis NA, Frants RR, van der Velden PA, Hille ET, Bergman W: Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 2000; 87: 809-811.
10. Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, Cruz-Correa M, Offerhaus JA: Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119: 1447-1453.
11. Rebours V, Boutron-Ruault MC, Schnee M, Ferec C, Maire F, Hammel P, Ruszniewski P, Levy P: Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol 2008; 103:111-119.
12. Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, Griffin C, Cameron JL, Yeo CJ, Kern S, Hruban RH: Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer research 2004; 64:2634-2638. (Pubitemid 38523922)
13. Hearle N, Schumacher V, Menko FH, Olschwang S, Boardman LA, Gille JJ, Keller JJ, Westerman AM, Scott RJ, Lim W, Trimbath JD, Giardiello FM, Gruber SB, Offerhaus GJ, de Rooij FW, Wilson JH, Hansmann A, Moslein G, Royer-Pokora B, Vogel T, Phillips RK, Spigelman AD, Houlston RS: Frequen -cy and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 2006; 12: 3209-3215.
14. van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, Hoogerbrugge N, Verhoef S, Vasen HF, Ausems MG, Menko FH, Gomez Garcia EB, Klijn JG, Hogervorst FB, van Houwelingen JC, van't Veer LJ, Rookus MA, van Leeuwen FE: Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 2005; 42: 711-719.
15. Thompson D, Easton DF: Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002; 94: 1358-1365. (Pubitemid 35154140)
16. Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, Bandipalliam P, Stoffel EM, Gruber SB, Syngal S: Risk of pancreatic cancer in fami lies with Ly nch sy ndrome. JAMA 2009; 302: 1790-1795.
17. Birkmeyer JD, Finlayson SR, Tosteson AN, Sharp SM, Warshaw AL, Fisher ES: Effect of hospital volume on inhospital mortality with pancreaticoduodenectomy. Surgery 1999; 125:250-256.
18. Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, Gallinger S: Prognostic factors in resected pancreatic adenocarcinoma: ana lysis of actua l 5 -year sur vivors. J Am Coll Surg 2004; 198: 722-731.
19. Kuhlmann KF, de Castro SM, Wesseling JG, ten Kate FJ, Offerhaus GJ, Busch OR, van Gulik TM, Obertop H, Gouma DJ: Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer 2004; 40: 549-558.
20. Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, Talamonti MS: Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer 2007; 110: 738-744.
21. Canto MI, Goggins M, Yeo CJ, Griffin C, Axilbund JE, Brune K, Ali SZ, Jagannath S, Petersen GM, Fishman EK, Piantadosi S, Giardiello FM, Hruban RH: Screening for pancreatic neoplasia in highrisk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 20 04; 2: 606-621.
22. Poley JW, Kluijt I, Gouma DJ, Harinck F, Wagner A, Aalfs C, van Eijck CH, Cats A, Kuipers EJ, Nio Y, Fockens P, Bruno MJ: The yield of firsttime endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol 2009; 104:2175-2181.
23. Maitra A, Fukushima N, Takaori K, Hruban RH: Precursors to invasive pancreatic cancer. Adv Anat Pat hol 2005; 12: 81-91.
24. Brune K, Abe T, Canto M, O'Malley L, Klein AP, Maitra A, Volkan Adsay N, Fishman EK, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RH: Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 2006; 30:1067-1076.
25. Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C, Fishman EK, Brune K, Axilbund J, Griffin C, Ali S, Richman J, Jagannath S, Kantsevoy SV, Kalloo AN: Screening for early pancreatic neoplasia in highrisk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006; 4: 766-781, quiz 665.
26. Langer P, Kann PH, Fendrich V, Habbe N, Schneider M, Sina M, Slater EP, Heverhagen JT, Gress TM, Rothmund M, Bartsch DK: Five years of prospective screening of highrisk individuals from families with familial pancreatic cancer. Gut 2009; 58: 1410-1418.
27. Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB: Early diagnosis and treatment of pancreatic dysplasia in patients wit h a family history of pancreatic cancer. Ann Intern Med 1999; 131: 247-255.
28. Tersmette AC, Petersen GM, Offerhaus GJ, Falatko FC, Brune KA, Goggins M, Rozenblum E, Wilentz RE, Yeo CJ, Cameron JL, Kern SE, Hruban RH: Increased risk of incident pancreatic cancer among firstdegree relatives of patients with familial pancreatic cancer. Clin Cancer Res 2001; 7:738-744.
29. Hruban RH, Maitra A, Goggins M: Update on pancreatic intraepithelial neoplasia. Int J Clin Exp Pathol 2008; 1:306-316.
30. Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, Biankin SA, Compton C, Fukushima N, Furukawa T, Goggins M, Kato Y, Kloppel G, Longnecker DS, Luttges J, Maitra A, Offerhaus GJ, Shimizu M, Yonezawa S: An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 20 04; 28: 977-987.
31. Tanaka M: Intraductal papillary mucinous neoplasm of the pancreas: diagnosis and treatment. Pancreas 2004; 28:282-8.
32. Canto MI, Schulick RD, Kamel IR, Fishman EK, Topazian MD, Takahashi N, Lee JH, Tamm EP, Vikram R, Syngal S, Saltzman JR, Mortele KJ, Farrell JJ, Margolis D, Zhang Z, Petersen GM, Hruban RH, Goggins MG: 415g: screening for familial pancreatic neoplasia: a prospective, multicenter blinded study of EUS, CT, and secretin-MRCP (The NCI-Spore Lustgarten Foundation Cancer of the Pancreas CAPS 3 Study). Gastrointest Endosc 2010;71:AB119.
33. Hunt GC, Faigel DO: Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review. Gastrointest Endosc 2002; 55: 232-237.
34. Muller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B: Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiolog y 1994; 19 0: 745-751.
35. Farrell JJ, Brugge WR: Intraductal papillary mucinous tumor of the pancreas. Gastrointest Endosc 2002; 55:701-714.
36. Pilleul F, Rochette A, Partensky C, Scoazec J Y, Bernard P, Valette PJ: Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings. J Magn Reson Imaging 2005; 21: 237-244.
37. Westerterp M, van Westreenen HL, Deutekom M, Stoker J, Fockens P, Comans EF, Plukker JT, Bossuyt PM, van Lanschot JJ, Sloof GW: Patients' perception of diagnostic tests in the preoperative assessment of esophageal cancer. Patient preference and adherence 2008; 2:157-162.
38. Harinck F, Nagtegaal T, Kluijt I, Aalfs CM, Smets E, Poley J-W, Wagner A, Fockens P, Hooft van JE, Bruno MJ, Bleiker E: W1155 burden of undergoing EUS-MRI based pancreatic cancer screening in highrisk individuals; first experiences. Gastroenterology 2010;138:S663.
39. Eshed I, Althoff CE, Hamm B, Hermann KG: Claustrophobia and premature termination of magnetic resonance imaging examinations. J Magn Reson Imaging 20 07; 26: 401-404.
40. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-767.
41. Chari ST, Yadav D, Smyrk TC, DiMagno EP, Miller LJ, Raimondo M, Clain JE, Norton IA, Pearson RK, Petersen BT, Wiersema MJ, Farnell MB, Sarr MG: Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002; 123:1500-1507.
42. Harinck F, Poley J-W, Hooft Van JE, Gouma DJ, Van Eijck CH, Nio CY, Hermans J, Cats A, Wagner A, Aalfs CM, Kluijt I, Fockens P, Bruno MJ: T1463: spontaneous resolvement of focal pancreatic lesions in EUS screening of individuals at high risk of pancreatic cancer. Gastrointest Endosc 2010;71:AB283- AB284.
43. Winawer SJ, Zauber AG, Ho MN, et al: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977-1981.
44. Petersen GM, de Andrade M, Goggins M, Hruban RH, Bondy M, Korczak JF, Gallinger S, Lynch HT, Syngal S, Rabe KG, Seminara D, Klein AP: Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2006; 15:704-710.